P3 Health Partners Inc

Finanzas de P3 Health Partners Inc (PIII)

$4.010

+0.199 (+4.97%)Al cierre

Rentabilidad y márgenes de PIII

Evaluating the bottom line, P3 Health Partners Inc maintains a gross margin of 22.26%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 10.67%, while the net margin is 4.05%. These profitability ratios, combined with a Return on Equity (ROE) of -87.57%, provide a clear picture of how effectively PIII converts its operational activities into shareholder value.

Comparativa sectorial de PIII

In the context of the broader market, PIII competes directly with industry leaders such as KPLT and KLTO. With a market capitalization of $29.11M, it holds a significant position in the sector. When comparing efficiency, PIII's gross margin of 22.26% stands against KPLT's 26.79% and KLTO's N/A. Such benchmarking helps identify whether P3 Health Partners Inc is trading at a premium or discount relative to its financial performance.

Desempeño financiero de P3 Health Partners Inc

P3 Health Partners has shown significant revenue growth, with Q2 2026 revenue at $386.4 million, a 9% increase year-over-year, and a notable recovery in net income, achieving $15.7 million compared to a loss last year.

Financials

FY2026Q2
YoY:
+8.60%
386.38M
Total Revenue
FY2026Q2
YoY:
-220.81%
41.23M
Operating Profit
FY2026Q2
YoY:
-135.84%
15.65M
Net Income after Tax
FY2025Q1
YoY:
+3896.31%
-314.11
EPS - Diluted
FY2026Q2
YoY:
+272.24%
-61.91M
Free Cash Flow
FY2026Q2
YoY:
-77.74%
22.26
Gross Profit Margin - %
FY2026Q2
YoY:
-2.69%
-8.68
FCF Margin - %
FY2026Q2
YoY:
-133.01%
4.05
Net Margin - %
FY2026Q2
YoY:
-3.81%
-79.04
ROIC

Artículos relacionados

Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.

Empezar a operar